ARTG 377287Angiography contrast medium injection system, line-powered, mobile
ARTG ID: 377287 · Intervene Medical Pty Ltd · Angiodroid SpA · Class IIb · Started November 02, 2021
Good Name: Intervene Medical Pty Ltd - Angiography contrast medium injection system, line-powered, mobile
- Risk Class
- Class IIb
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 377287
- Start Date
- November 02, 2021
- Effective Date
- November 02, 2021
- Name
- Angiodroid SpA
- Country
- Italy
- Address
- Via Speranza 35, San Lazzaro di Savena, BO, 40068
The device allows the intravascular injection of CO2, with precise volume dose and injection pressure, to perform Automated Carbon Dioxide Angiography (ACDA). CO2 acts as a contrast agent in an angiographic examination.
Access comprehensive regulatory information for Angiography contrast medium injection system, line-powered, mobile in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 377287 and sponsored by Intervene Medical Pty Ltd, manufactured by Angiodroid SpA in Italy. The device registration started on November 02, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.